Daxor Corporation

NasdaqCM DXR

Daxor Corporation Market Capitalization on January 14, 2025: USD 40.80 M

Daxor Corporation Market Capitalization is USD 40.80 M on January 14, 2025, a -14.77% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.

Daxor Corporation 52-week high Market Capitalization is USD 48.21 M on January 18, 2024, which is 18.15% above the current Market Capitalization.
Daxor Corporation 52-week low Market Capitalization is USD 34.56 M on March 04, 2024, which is -15.30% below the current Market Capitalization.
Daxor Corporation average Market Capitalization for the last 52 weeks is USD 42.86 M.

Key data

Date	Market Capitalization	Share Price	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)

NasdaqCM: DXR

Daxor Corporation

CEO	Mr. Michael Richard Feldschuh
IPO Date	July 25, 1983
Location	United States
Headquarters	109 Meco Lane
Employees	37
Sector	Health Care
Industries Medical Instruments Biotechnology Pharmaceuticals

Description

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee.

Key trends

Past 5 years